{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:10:25Z","timestamp":1787497825538,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1991,11,1]],"date-time":"1991-11-01T00:00:00Z","timestamp":688953600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[1991,11]]},"DOI":"10.1007\/bf01698371","type":"journal-article","created":{"date-parts":[[2005,6,10]],"date-time":"2005-06-10T16:08:25Z","timestamp":1118419705000},"page":"235-241","source":"Crossref","is-referenced-by-count":49,"title":["Myelodysplastic syndromes with bone marrow fibrosis: a myelodysplastic disorder with proliferative features"],"prefix":"10.1007","volume":"63","author":[{"given":"G. E. G.","family":"Verhoef","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"De Wolf-Peeters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ferrant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Deprez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Meeus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Stul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Zache\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. J.","family":"Cassiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Van den Berghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Boogaerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF01698371_CR1","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/309804a0","volume":"309","author":"RK Assoian","year":"1984","unstructured":"Assoian RK, Grotendorst GR, Miller DM, Sporn MB (1984) Cellular transformation by coordination of three peptide growth factors from human platelets. Nature 309: 806","journal-title":"Nature"},{"key":"BF01698371_CR2","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1182\/blood.V58.2.206.206","volume":"58","author":"BJ Bain","year":"1981","unstructured":"Bain BJ, Catovsky D, O'Brien M, Prentice HG, Lawlor E, Kumaran TO, McCann SR, Matutes E, Galton DAG (1981) Megakaryoblastic leukemia presenting as acute myelofibrosis. A study of four cases with the platelet-peroxidase reaction. Blood 58: 206\u2013213","journal-title":"Blood"},{"key":"BF01698371_CR3","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2141.1981.tb08459.x","volume":"48","author":"G Barosi","year":"1981","unstructured":"Barosi G, Cazzola M, Frassoni F, Orlandi E, Stefanelli M (1981) Erythropoiesis in myelofibrosis with myeloid metaplasia: recognition of different classes of patients by erythrokinetics. Br J Haematol 48: 263\u2013272","journal-title":"Br J Haematol"},{"key":"BF01698371_CR4","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/1097-0142(197901)43:1<279::AID-CNCR2820430141>3.0.CO;2-L","volume":"43","author":"RM Bearman","year":"1979","unstructured":"Bearman RM, Pangalis G, Rappaport H (1979) Acute (\u201cmalignant\u201d) myelosclerosis. Cancer 43: 279\u2013293","journal-title":"Cancer"},{"key":"BF01698371_CR5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","volume":"51","author":"JM Bennett","year":"1982","unstructured":"Bennett JM, Catovsky D, Daniel MT, Galton DAG, Gralnick HR, Sultan C (1982) Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51: 189\u2013199","journal-title":"Br J Haematol"},{"key":"BF01698371_CR6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2141.1977.tb05753.x","volume":"36","author":"SA Bentley","year":"1977","unstructured":"Bentley SA, Murray KH, Lewis SM, Roberts PD (1977) Erythroid hypoplasia in myelofibrosis: a feature associated with blastic transformation. Br J Hematol 36: 41\u201347","journal-title":"Br J Hematol"},{"key":"BF01698371_CR7","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000205913","volume":"78","author":"G Castoldi","year":"1987","unstructured":"Castoldi G, Cuneo A, Tomasi P, Ferrari L (1987) Chromosome abnormalities in myelofibrosis. Acta Haematol 78: 104\u2013108","journal-title":"Acta Haematol"},{"key":"BF01698371_CR8","first-page":"427","volume-title":"Myelofibrosis and the biology of connective tissue","author":"H Castro-Malaspina","year":"1984","unstructured":"Castro-Malaspina H (1984) Pathogenesis of myelofibrosis: role of ineffective megakaryopoiesis and megakaryocyte components. In: Berk PD, Castro-Malaspina H, Wasserman LR (eds) Myelofibrosis and the biology of connective tissue. Alan R Liss, New York pp 427\u2013454"},{"key":"BF01698371_CR9","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1182\/blood.V57.4.781.781","volume":"57","author":"H Castro-Malaspina","year":"1981","unstructured":"Castro-Malaspina H, Rabellio EM, Yen A, Nachman RL, Moore MAS (1981) Human megakaryocyte stimulation of proliferation of bone marrow fibroblasts. Blood 57: 781\u2013787","journal-title":"Blood"},{"key":"BF01698371_CR10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0165-4608(84)90009-8","volume":"12","author":"MP Davis","year":"1984","unstructured":"Davis MP, Dewald GW, Pierre RV, Hoagland HC (1984) Hematological manifestations associated with deletions of the long arm of chromosome 20. Cancer Genet Cytogenet 12: 63\u201371","journal-title":"Cancer Genet Cytogenet"},{"key":"BF01698371_CR11","first-page":"111","volume":"2","author":"L Elias","year":"1987","unstructured":"Elias L, Van Epps DE, Smith KJ, Savage B (1987) A trial of recombinant\u03b1 2 interferon in the myelodysplastic syndrome. II. Characterization and response of granulocyte and platelet dysfunction. Leukemia 2: 111\u2013115","journal-title":"Leukemia"},{"key":"BF01698371_CR12","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/0003-2697(84)90381-6","volume":"137","author":"A Feinberg","year":"1984","unstructured":"Feinberg A, Vogelstein B (1984) A technique for radiolabeling DNA restriction endonuclease fragments to high activity. Ann Biochem 137: 266\u2013267","journal-title":"Ann Biochem"},{"key":"BF01698371_CR13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2141.1988.tb02433.x","volume":"70","author":"P Felman","year":"1988","unstructured":"Felman P, Bryon P, Gentilomme O, Ferench M, Charrin C, Espinouse D, Viala JJ (1988) The syndrome of abnormal chromatin clumping in leukocytes: a myelodysplastic disorder with proliferative features. Br J Haematol 70: 49\u201354","journal-title":"Br J Haematol"},{"key":"BF01698371_CR14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2141.1987.tb06142.x","volume":"65","author":"P Fenaux","year":"1987","unstructured":"Fenaux P, Jouet JP, Zandecki M, Lai JL, Simon M, Pollet JP, Bauters F (1987) Chronic and subacute myelomonocytic leukaemia in the adult: a report of 60 cases with special reference to prognostic factors. Br J Haematol 65: 101\u2013106","journal-title":"Br J Haematol"},{"key":"BF01698371_CR15","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1365-2141.1980.tb07164.x","volume":"45","author":"A Ferrant","year":"1980","unstructured":"Ferrant A, Cauwe F, Cogneau M, Beckers C, Verwilghen RL, Sokal G (1980) Measurement of erythropoiesis using52Fe. Br J Haematol 45: 447\u2013457","journal-title":"Br J Haematol"},{"key":"BF01698371_CR16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1600-0609.1982.tb00611.x","volume":"29","author":"A Ferrant","year":"1982","unstructured":"Ferrant A, Rodhain J, Cauwe F, Cogneau M, Beckers C, Michaux JL, Verwilghen RL, Sokal G (1982) Assessment of bone marrow and splenic erythropoiesis in myelofibrosis. Scand J Haematol 29: 373\u2013380","journal-title":"Scand J Haematol"},{"issue":"Suppl 45","key":"BF01698371_CR17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0609.1986.tb00839.x","volume":"36","author":"DAG Galton","year":"1986","unstructured":"Galton DAG (1986) The myelodysplastic syndromes. Scand J Haematol 36 [Suppl 45]: 11\u201320","journal-title":"Scand J Haematol"},{"key":"BF01698371_CR18","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1182\/blood.V70.4.1173.1173","volume":"70","author":"A Ganser","year":"1987","unstructured":"Ganser A, Carlo-Stella C, Greher J, Volkers B, Hoelzer D (1987) Effect of recombinant interferons\u03b1 and \u03b3 on human bone marrow-derived megakaryocytic progenitor cells. Blood 70: 1173\u20131179","journal-title":"Blood"},{"key":"BF01698371_CR19","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1365-2141.1990.tb07871.x","volume":"76","author":"AD Geddes","year":"1990","unstructured":"Geddes AD, Bowen DT, Jacobs A (1990) Clonal karyotype abnormalities and clinical progress in the myelodysplastic syndrome. Br J Haematol 76: 194\u2013202","journal-title":"Br J Haematol"},{"key":"BF01698371_CR20","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-92-6-857","volume":"92","author":"JE Groopman","year":"1980","unstructured":"Groopman JE (1980) The pathogenesis of myelofibrosis in myeloproliferative disorders. Ann Intern Med 92: 857\u2013858","journal-title":"Ann Intern Med"},{"key":"BF01698371_CR21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/ajh.2830280104","volume":"28","author":"M Gyger","year":"1988","unstructured":"Gyger M, Infante-Rivard C, D'Angelo G, Forest L, Lussier P (1988) Prognostic value of clonal chromosomal abnormalities in patients with primary myelodysplastic syndromes. Am J Hematol 28: 13\u201320","journal-title":"Am J Hematol"},{"key":"BF01698371_CR22","first-page":"129","volume-title":"Cancer cytogenesis","author":"S Heim","year":"1987","unstructured":"Heim S, Mitelman F (1987) Cancer cytogenesis. Alan R Liss, New York, pp 129\u2013140"},{"key":"BF01698371_CR23","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1182\/blood.V38.3.378.378","volume":"38","author":"International Committee for Standardization in Haematology","year":"1971","unstructured":"International Committee for Standardization in Haematology (1971) Recommended methods for radioisotope red cell survival. Blood 38: 378\u2013386","journal-title":"Blood"},{"key":"BF01698371_CR24","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1136\/jcp.38.11.1201","volume":"38","author":"A Jacobs","year":"1985","unstructured":"Jacobs A (1985) Myelodysplastic syndromes: pathogenesis, functional abnormalities and clinical implications. J Clin Pathol 38: 1201\u20131217","journal-title":"J Clin Pathol"},{"key":"BF01698371_CR25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1600-0609.1990.tb00459.x","volume":"45","author":"A Ja\u00e9n","year":"1990","unstructured":"Ja\u00e9n A, Irriguible D, Milla F, Vallespi T, Torrabadella M, Abella E, Lafuente R, Woessner S (1990) Abnormal chromatin clumping in leukocytes: a clue to a new subtype of myelodysplastic syndrome. Eur J Haematol 45: 209\u2013214","journal-title":"Eur J Haematol"},{"key":"BF01698371_CR26","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2141.1987.tb06138.x","volume":"61","author":"H Kerkhofs","year":"1987","unstructured":"Kerkhofs H, Hermans I, Haak HL, Leeksma CHW (1987) Utility of the FAB classification for myelodysplastic syndromes: investigation of prognostic factors in 237 cases. Br J Haematol 61: 73\u201381","journal-title":"Br J Haematol"},{"key":"BF01698371_CR27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2141.1988.tb07595.x","volume":"69","author":"A Kimura","year":"1988","unstructured":"Kimura A, Katoh O, Kuramoto A (1988) Effects of plateletderived growth factor, epidermal growth factor, and transforming growth factor-\u03b2 on the growth of human marrow fibroblast. Br J Haematol 69: 9\u201312","journal-title":"Br J Haematol"},{"key":"BF01698371_CR28","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2141.1988.tb07616.x","volume":"69","author":"A Kimura","year":"1988","unstructured":"Kimura A, Katoh O, Kuramoto A (1988) Marrow fibroblasts from patients with myeloproliferative disorders show increased sensitivity to human serum mitogens. Br J Haematol 69: 153\u2013156","journal-title":"Br J Haematol"},{"key":"BF01698371_CR29","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2141.1991.tb04411.x","volume":"78","author":"G Lambertenghi-Deliliers","year":"1991","unstructured":"Lambertenghi-Deliliers G, Orazi A, Luksch R, Annaloro C, Soligo D (1991) Myelodysplastic syndrome with increased marrow fibrosis: a distinct clinico-pathological entity. Br J Haematol 78: 161\u2013166","journal-title":"Br J Haematol"},{"key":"BF01698371_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2141.1985.tb02956.x","volume":"59","author":"DM McCarthy","year":"1985","unstructured":"McCarthy DM (1985) Fibrosis of the bone marrow: content and causes. Br J Haematol 59: 1\u20137","journal-title":"Br J Haematol"},{"key":"BF01698371_CR31","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2141.1979.tb03740.x","volume":"43","author":"A Manoharan","year":"1979","unstructured":"Manoharan A, Horsley R, Pitney WR (1979) The reticulin content of bone marrow in acute leukaemia in adults. Br J Haematol 43: 185\u2013190","journal-title":"Br J Haematol"},{"key":"BF01698371_CR32","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2141.1985.tb02996.x","volume":"59","author":"SJ May","year":"1985","unstructured":"May SJ, Smith SA, Jacobs A, Williams A, Bailey-Wood R (1985) The myelodysplastic syndrome: analysis of laboratory characteristics in relation to the FAB classification. Br J Haematol 59: 311\u2013319","journal-title":"Br J Haematol"},{"key":"BF01698371_CR33","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.1016\/S0021-9258(18)61316-X","volume":"262","author":"K Miyazono","year":"1987","unstructured":"Miyazono K, Okabe T, Urabe A, Takaku F, Heldin CH (1987) Purification and properties of an endothelial cell growth factor from human platelets. J Biol Chem 262: 4098\u20135003","journal-title":"J Biol Chem"},{"key":"BF01698371_CR34","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2141.1978.tb03658.x","volume":"40","author":"Y Najean","year":"1978","unstructured":"Najean Y, Cacchione R, Castro-Malaspina H, Dresch C (1978) Erythrokinetic studies in myelofibrosis: their significance for prognosis. Br J Haematol 40: 205\u2013217","journal-title":"Br J Haematol"},{"key":"BF01698371_CR35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2141.1979.tb03693.x","volume":"42","author":"GJ Ottolander den","year":"1979","unstructured":"Ottolander GJ den, te Velde J, Brederoo P, Geraedts JPM, Slee PHT, Willemze R, Zwaan FE, Haak HL, Muller HP, Bieger R (1979) Megakaryoblastic leukaemia (acute myelofibrosis): a report of three cases. Br J Haematol 42: 9\u201320","journal-title":"Br J Haematol"},{"key":"BF01698371_CR36","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1365-2141.1989.tb06309.x","volume":"71","author":"A Pagliuca","year":"1989","unstructured":"Pagliuca A, Layton DM, Manoharan A, Gordon S, Green PJ, Mufti GJ (1989) Myelofibrosis in primary myelodysplastic syndromes: a clinico-morphological study of 10 cases. Br J Haematol 71: 499\u2013504","journal-title":"Br J Haematol"},{"key":"BF01698371_CR37","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0165-4608(87)90183-X","volume":"25","author":"G Rege-Cambrin","year":"1987","unstructured":"Rege-Cambrin G, Mecucci C, Tricot G, Michaux JI, Louwagie A, van Hove W, Francart H, Van Den Berghe H (1987) A chromosomal profile of polycythemia vera. Cancer Genet Cytogenet 25: 233\u2013245","journal-title":"Cancer Genet Cytogenet"},{"key":"BF01698371_CR38","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-2141.1975.tb00833.x","volume":"31","author":"C Ricketts","year":"1975","unstructured":"Ricketts C, Jacobs A, Cavill I (1975) Ferrokinetics and erythropoiesis in man: the measurement of effective erythropoiesis, ineffective erythropoiesis and red cell life span using59Fe. Br J Haematol 31: 65\u201375","journal-title":"Br J Haematol"},{"key":"BF01698371_CR39","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1182\/blood.V74.1.395.395","volume":"74","author":"GF Sanz","year":"1989","unstructured":"Sanz GF, Sanz MA, Vallespi T, Ca\u00f1izo MC, Torrabadella M, Garcia S, Irriguible D, San Miguel JF (1989) Two progression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. Blood 74: 395\u2013408","journal-title":"Blood"},{"key":"BF01698371_CR40","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1182\/blood.V63.3.634.634","volume":"63","author":"P Solal-Celigny","year":"1984","unstructured":"Solal-Celigny P, Desaint B, Herrera A, Chastang G, Amar M, Vroclans M, Broussa N, Mancilla F, Renoux M, Bernard JF, Boivin P (1984) Chronic myelomonocytic leukaemia according to FAB classification. Analysis of 35 cases. Blood 63: 634\u2013638","journal-title":"Blood"},{"key":"BF01698371_CR41","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1182\/blood.V72.2.386.386","volume":"72","author":"B Swolin","year":"1988","unstructured":"Swolin B, Weinfeld A, Westin J (1988) A prospective long-term cytogenetic study in polycythemia vera in relation to treatment and clinical course. Blood 72: 386\u2013395","journal-title":"Blood"},{"key":"BF01698371_CR42","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-2141.1984.tb02916.x","volume":"57","author":"G Tricot","year":"1984","unstructured":"Tricot G, De Wolf-Peeters C, Hendrickx B, Verwilghen RL (1984) Bone marrow histology in myelodysplastic syndromes. I. Histological findings in myelodysplastic syndromes and comparison with bone marrow smears. Br J Haematol 57: 423\u2013430","journal-title":"Br J Haematol"},{"key":"BF01698371_CR43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2141.1985.tb07381.x","volume":"60","author":"G Tricot","year":"1985","unstructured":"Tricot G, Vlietinck R, Boogaerts MA, Hendrickx B, De WolfPeeters C, Van Den Berghe H, Verwilghen RL (1985) Prognostic factors in the myelodysplastic syndromes: importance of initial data on peripheral blood counts, bone marrow cytology, trephine biopsy and chromosomal analysis. Br J Haematol 60: 19\u201332","journal-title":"Br J Haematol"},{"key":"BF01698371_CR44","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2141.1990.tb02603.x","volume":"45","author":"GEG Verhoef","year":"1990","unstructured":"Verhoef GEG, De Wolf-Peeters C, Ferrant A, Boogaerts MA (1990) A case of myelodysplastic syndrome and myelofibrosis. Br J Haematol 45: 373\u2013375","journal-title":"Br J Haematol"},{"issue":"4","key":"BF01698371_CR45","first-page":"163","volume":"5","author":"G Verhoef","year":"1991","unstructured":"Verhoef G, De Wolf-Peeters C, Kerim S, Van De Broeck J, Mecucci C, Van Den Berghe H, Boogaerts M (1991) Update on the prognostic implication of morphology, histology and karyotype in primary myelodysplastic syndromes. Hematol Pathol 5 (4): 163\u2013175","journal-title":"Hematol Pathol"},{"key":"BF01698371_CR46","doi-asserted-by":"crossref","unstructured":"Verhoef G, Meeus P, Stul M, Mecucci C, Cassiman JJ, Van Den Berghe H, Boogaerts M (1991) Cytogenetic and molecular studies of the Philadelphia translocation in the myelodysplastic syndromes: report of 2 cases and review of the literature. Cancer Genet Cytogenet (in press)","DOI":"10.1016\/0165-4608(92)90209-Q"},{"key":"BF01698371_CR47","first-page":"188 a","volume":"70","author":"JC Wang","year":"1987","unstructured":"Wang JC, Lang HD (1987) Recombinant\u03b1 interferon inhibits the proliferation of bone marrow fibroblasts cultured from patients with myelofibrosis and myeloid metaplasia (MMM). Blood 70: 188 a","journal-title":"Blood"},{"key":"BF01698371_CR48","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00005792-197109000-00001","volume":"50","author":"HP Ward","year":"1971","unstructured":"Ward HP, Block MH (1971) The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome. Medicine 50: 357\u2013420","journal-title":"Medicine"},{"key":"BF01698371_CR49","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1056\/NEJM198905043201807","volume":"320","author":"CW White","year":"1989","unstructured":"White CW, Sondheimer HM, Crouch EC, Wilson H, Fan LL (1989) Treatment of pulmonary hemangiomatosis with recombinant interferon \u03b1-2a. N Engl J Med 320: 1197\u20131200","journal-title":"N Engl J Med"},{"key":"BF01698371_CR50","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1182\/blood.V65.4.803.803","volume":"65","author":"BC Wolf","year":"1985","unstructured":"Wolf BC, Neiman RS (1985) Myelofibrosis with myeloid metaplasia: Pathophysiologic implications of the correlation between bone marrow changes and progression of splenomegaly. Blood 65: 803\u2013809","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01698371.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01698371\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01698371","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T09:06:32Z","timestamp":1706259992000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01698371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,11]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1991,11]]}},"alternative-id":["BF01698371"],"URL":"https:\/\/doi.org\/10.1007\/bf01698371","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,11]]}}}